Yes, chemical modification of haptens is a strategy used to reduce their immunogenicity and toxicity. By altering the chemical structure of a hapten, it is possible to prevent its binding to carrier proteins, thereby reducing the risk of an immune response. This approach is particularly useful in drug development, where minimizing adverse drug reactions is a critical goal.
